Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Cell type, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Closed
Phase 2
This trial is looking at whether atezolizumab can improve treatment for a people with a type of non-Hodgkin lymphoma called diffuse B cell lymphoma (DBCL). The trial is for people:
whose lymphoma has come back or continued to grow following at least 1 or 2 different types of treatment
who are not suitable for high dose chemotherapy
Cancer Research UK supports this trial.
Recruitment start: 9 May 2018
Recruitment end: 19 June 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Andrew Davies
Cancer Research UK
Roche
Southampton Clinical Trials Unit
University Hospital Southampton NHS Foundation Trust
This is Cancer Research UK trial number CRUKE/16/028.
Last reviewed: 27 June 2024
CRUK internal database number: 15323
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
